Sincalide
FDA-approved diagnostic CCK analog (Kinevac).
What it's for
Sincalide is the synthetic C-terminal 8–amino-acid peptide of cholecystokinin. It is used as a diagnostic aid to stimulate gallbladder contraction or pancreatic enzyme secretion during imaging/testing.
What it does for the body
It is used as a diagnostic aid to stimulate gallbladder contraction or pancreatic enzyme secretion during imaging/testing. People often hear about it through clinics, forums, or news — this guide sticks to what published research and regulators actually support.
What it targets
CCK receptors (lock-and-key landing spots on cells) activation contracts the gallbladder and stimulates pancreatic exocrine secretion. Researchers map these ideas in cells and animals first; human proof has to clear a higher bar.
Research context
Bottom line for readers: Sincalide has a defined FDA-approved story. Use the citations tab to open labels and trial registries, and treat anything beyond the label as unverified.
Studied for (literature interest)
- Digestive research interest (educational tag)
Cautions (educational)
- Educational only — not medical advice.
- DrPep does not offer medical consultations, dosing guidance, suppliers, or peptide sales.
Citations / starters
- FDA search: Sincalide — FDA.gov search
- ClinicalTrials.gov search: Sincalide — U.S. clinical trials registry
- Drugs@FDA search: Sincalide — FDA drug database (if approved)
- PubMed search: Sincalide — NCBI PubMed
- PubMed Central search: Sincalide — NCBI PMC